Suven Life Science is exhibiting and presenting several exciting new results and data presentations from Suven’s portfolio of investigational neuroscience New Chemical Entities (NCEs) are being presented at Alzheimer's Association International Conference (AAIC) being held in London, England starting July 16th to 19th, 2017.
AAIC is the world's largest conference of its kind, where thousands of international investigators, clinicians, researchers and care providers will gather to share the latest study results, theories and discoveries bringing the world closer to breakthroughs in dementia science.
Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.
